Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arisaig Asia Fund Ltd F K A Arisaig Asia Consumer Fund Ltd
Thyrocare spurts after 5% equity changes hands
The deal comes two weeks after the company met with Artisan Partners and Grandeur Peak Global Fund
Nomura India's head of investment banking steps down
During his tenure at the company, Oza played a key role in various deals, including Nomura's sale of ASK Group to Blackstone and the sale of diagnostics firm Thyrocare to healthcare firm PharmEasy. Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon Life India Trustee Ltd Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investors/Analysts Thyrocare Technologies Ltd - 539871 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the Listing Regulation read with SEBI circular no CIR/CFD/CMD1/27/2019 dated February 8, 2019, BSE Notice No. 20230316-14 and NSE Circular Ref No: NSE/CML/2023/21 both dated March 16, 2023, please find enclosed herewith Annual Secretarial Compliance Report for the financial year ended March 31, 2023 issued by V Suresh Associates, Secretarial Auditors of the Company. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investors/Analysts Thyrocare Technologies Ltd - 539871 - Announcement Under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Disclosure under Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Thyrocare Technologies Ltd - 539871 - Audio Recording Of Analyst And Investor Conference Call For Audited Financial Results Of The Company For The Financial Year Ended March 31, 2023.
Audio Recording of Analyst and Investor Conference Call For Audited Financial Results of The Company For The Financial Year Ended March 31, 2023.